
Early-stage venture fund taking science and engineering research from labs to market

Life sciences venture fund investing in early-stage biomedical projects around the world

RBV Capital is a venture capital fund dedicated to life sciences, set up in 2014. It puts money into early-stage biomedical projects across the globe and aims to build a spread of breakthrough assets.
The fund works with early-stage life sciences companies worldwide. Its site separates current investments, exited investments and the wider portfolio.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about RBV Capital.
Similar listings buyers compare against this one.

Early-stage venture fund taking science and engineering research from labs to market

Investment manager backing early-stage cannabis and other emerging-industry companies for institutional investors

Oslo-based private investment company backing early and later-stage life science businesses

Life science investor putting money into young oncology and genetic disease drug developers

Investment and advisory firm holding and selling stakes in growth companies

US law firm advising start-ups, venture capital and growth equity funds and technology companies
Everything here links back to the same verified catalogue. Pick your next stop.